Key Financial Data Of Reporting Company

Kidswell Bio Corporation - Filing #7601153

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
1,569,232,000 JPY
1,569,232,000 JPY
967,000,000 JPY
996,543,000 JPY
964,345,000 JPY
1,077,737,000 JPY
1,021,703,000 JPY
JPY
1,059,727,000 JPY
JPY
Ordinary profit (loss)
-968,535,000 JPY
-952,640,000 JPY
-956,432,000 JPY
-991,166,000 JPY
-1,007,062,000 JPY
-1,187,254,000 JPY
-816,412,000 JPY
JPY
-903,215,000 JPY
JPY
Profit (loss)
-550,863,000 JPY
-1,001,442,000 JPY
-7,316,415,000 JPY
-856,291,000 JPY
-904,557,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
1,421,212,000 JPY
1,032,179,000 JPY
611,711,000 JPY
591,338,000 JPY
100,000,000 JPY
Total number of issued shares
31,437,547 xbrli:shares
29,622,847 xbrli:shares
27,646,986 xbrli:shares
20,342,446 xbrli:shares
9,567,923 xbrli:shares
Net assets
1,718,513,000 JPY
1,702,908,000 JPY
1,610,385,000 JPY
1,610,385,000 JPY
1,487,390,000 JPY
1,487,371,000 JPY
JPY
2,731,269,000 JPY
2,604,037,000 JPY
JPY
Total assets
3,503,335,000 JPY
3,470,336,000 JPY
3,933,952,000 JPY
3,897,851,000 JPY
3,592,139,000 JPY
3,524,700,000 JPY
JPY
3,151,358,000 JPY
3,025,172,000 JPY
JPY
Net assets per share
48.79
48.30
50.44
50.44
51.73
51.73
132.55
134.37
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-17.86
-17.35
-34.79
-34.79
-264.65
-264.65
-43.84
-47.27
Diluted earnings per share
Equity-to-asset ratio
0.438 xbrli:pure
0.438 xbrli:pure
0.380 xbrli:pure
0.383 xbrli:pure
0.398 xbrli:pure
0.406 xbrli:pure
xbrli:pure
0.856 xbrli:pure
0.850 xbrli:pure
xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
JPY
-1,169,561,000 JPY
JPY
-1,267,471,000 JPY
JPY
-1,325,059,000 JPY
-860,316,000 JPY
JPY
-438,372,000 JPY
JPY
Net cash provided by (used in) investing activities
JPY
526,509,000 JPY
JPY
-22,290,000 JPY
JPY
-137,206,000 JPY
-27,000 JPY
JPY
-50,252,000 JPY
JPY
Net cash provided by (used in) financing activities
JPY
369,083,000 JPY
JPY
718,345,000 JPY
JPY
1,221,771,000 JPY
978,446,000 JPY
JPY
JPY
JPY
Cash and cash equivalents
1,187,189,000 JPY
JPY
1,461,158,000 JPY
JPY
2,032,575,000 JPY
JPY
JPY
2,009,373,000 JPY
1,891,271,000 JPY
JPY
Number of employees
38 xbrli:pure
38 xbrli:pure
39 xbrli:pure
39 xbrli:pure
45 xbrli:pure
29 xbrli:pure
xbrli:pure
26 xbrli:pure
21 xbrli:pure
xbrli:pure
Total shareholder return
0.659 xbrli:pure
0.723 xbrli:pure
0.751 xbrli:pure
1.250 xbrli:pure
1.939 xbrli:pure
Total return on share price index
0.738 xbrli:pure
1.124 xbrli:pure
0.579 xbrli:pure
0.893 xbrli:pure
1.126 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.